Study That Tests AD109 in Patients Taking GLP-1 Drugs

Summary

Phase 2 Safety, Efficacy and, Tolerability of Fixed Dose Combination of Aroxybutynin/Atomoxetine (AD109) in Obstructive Sleep Apnea Patients Taking Tirzepatide, Semaglutide or Liraglutide

Timeline

Start

2024-05-20

Primary completion

2024-12-26

Completion

2024-12-26

Drugs

Indications